Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCapital LeasesCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Maravai Lifesciences Holdings (MRVI) Cash & Current Investments: 2022-2025

Historic Cash & Current Investments for Maravai Lifesciences Holdings (MRVI) over the last 3 years, with Sep 2025 value amounting to $243.6 million.

  • Maravai Lifesciences Holdings' Cash & Current Investments fell 57.87% to $243.6 million in Q3 2025 from the same period last year, while for Sep 2025 it was $1.1 billion, marking a year-over-year decrease of 51.09%. This contributed to the annual value of $323.8 million for FY2024, which is 43.69% down from last year.
  • Latest data reveals that Maravai Lifesciences Holdings reported Cash & Current Investments of $243.6 million as of Q3 2025, which was down 9.76% from $269.9 million recorded in Q2 2025.
  • Maravai Lifesciences Holdings' 5-year Cash & Current Investments high stood at $632.1 million for Q4 2022, and its period low was $243.6 million during Q3 2025.
  • Moreover, its 3-year median value for Cash & Current Investments was $568.3 million (2023), whereas its average is $457.7 million.
  • Data for Maravai Lifesciences Holdings' Cash & Current Investments shows a maximum YoY plummeted of 57.87% (in 2025) over the last 5 years.
  • Quarterly analysis of 4 years shows Maravai Lifesciences Holdings' Cash & Current Investments stood at $632.1 million in 2022, then declined by 9.04% to $575.0 million in 2023, then crashed by 43.69% to $323.8 million in 2024, then tumbled by 57.87% to $243.6 million in 2025.
  • Its Cash & Current Investments was $243.6 million in Q3 2025, compared to $269.9 million in Q2 2025 and $285.1 million in Q1 2025.